Core Viewpoint - Piper Sandler has raised its price target on Doximity Inc. to $42 from $40 while maintaining an Overweight rating, indicating a positive outlook on the company's stock performance [1] Group 1: Doximity's AI Tool Suite - Insights from a demonstration led by CEO Jeff Tangney highlighted the strengths of Doximity's AI tool suite, particularly DoxGPT, which is noted for its integration within the Doximity ecosystem, the quality and accuracy of clinical reference responses, and a strong evidence base supporting its medical AI capabilities [2] - A new feature called PeerCheck allows healthcare professionals to efficiently transition from clinical questions to citations and original sources, enhancing the utility of DoxGPT [2] Group 2: Market Potential and Stock Valuation - As AI tools like Scribe and DoxGPT become integrated into Doximity's workflow platform, there is an expectation of increased adoption among individual healthcare professionals and enterprise contracts with hospitals and health systems, creating a virtuous cycle [3] - Piper Sandler believes the market is undervaluing DoxGPT's potential, especially following the fiscal third-quarter 2026 EPS results, leading to an updated price target of $42 based on a 20.0x multiple applied to slightly higher calendar 2027 adjusted EBITDA estimates [4]

SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast o ...

Core Insights - HEALWELL AI Inc. and WELL Health Technologies Corp. have launched WELLTRUST™, a platform designed for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada [1][10]. Company Overview - HEALWELL AI focuses on preventative care through healthcare artificial intelligence, aiming to improve healthcare outcomes by early disease detection and clinical decision support systems [7]. - WELL Health Technologies aims to empower healthcare providers through technology, operating over 240 clinics in Canada and serving more than 43,000 healthcare providers across North America [8]. Platform Features - WELLTRUST accelerates clinical research recruitment by allowing patients to consent to future outreach for clinical trials, combining WELL's clinical footprint with HEALWELL's AI capabilities [2][10]. - The platform provides a privacy-preserving infrastructure that enables ethical patient identification and research acceleration while allowing patients to opt-out if they choose [2][11]. - WELLTRUST includes a robust governance and compliance framework to meet Canadian privacy standards, facilitating partnerships with pharmaceutical sponsors and research organizations [11]. Leadership Commentary - Dr. Alexander Dobranowski from HEALWELL emphasized the platform's commitment to responsible AI in healthcare, aiming to enhance patient access to innovations while maintaining privacy [3]. - Dr. Michael Frankel from WELL highlighted the importance of technology in improving healthcare outcomes and empowering patients to participate in research safely [5].

HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China. These subsidiaries are primarily dedicated to localized market expansion, institutional partnerships, and frontline sales execution for GV’s regenerative medicine, cellula ...

Hinge Health, Inc. (NYSE:HNGE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares Hinge Health, Inc. (NYSE:HNGE) secures third place on our list of innovative healthcare stocks. TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares. The analyst pointed out that the retreat offers an interesting chance for investo ...

We recently published 10 Stocks Outperforming With Monstrous Gains. Waystar Holding Corp. (NASDAQ:WAY) was one of the best performers on Tuesday. Waystar saw its share prices jump by 8.48 percent on Tuesday to close at $24.31 apiece as investors cheered its swing to profitability and a double-digit growth outlook for this year. In an updated report, Waystar Holding Corp. (NASDAQ:WAY) said that it swung to a net income of $112 million last year, reversing a $19 million net loss in 2024. Revenues broke pa ...

Waystar Holding Corp. (NASDAQ:WAY) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks The fourth stock on this list is Waystar Holding Corp. (NASDAQ:WAY). TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating. The reduction reflects the firm’s reassessment of competitive risks within the healthcare technolo ...

WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Heal ...

Last year, Chris Heckler was coming to the end of a five-year non-compete after selling his last company, a healthcare startup. “I was sitting on the sidelines doing angel investing, and I realized I was too young to retire,” he told TechCrunch. “I wanted to get back into it.” At the same time, Joseph Akintolayo had just sold his fintech company. He, too, had a non-compete, but was noodling on ideas for a company. He knew Heckler, as Akintolayo had once served as an advisor on one of his projects. In ...

Core Insights - Waystar has been recognized as an Inc. Best in Business honoree in the Best AI Implementation category, highlighting its excellence in AI execution and significant business impact [1][5] Group 1: AI Implementation and Impact - The rapid market adoption of Waystar AltitudeAI has led to clients preventing $15.5 billion in denials, achieving 95% time savings in denial prevention workflows, and increasing denial overturn rates by double digits [2] - Waystar's AI advantage is based on a mission-critical system of record that integrates financial, clinical, and administrative intelligence, allowing AI agents to resolve payment issues effectively [3] Group 2: Client Success and Growth - Advocate Health, a large nonprofit health system, utilizes Waystar's software to enhance administrative workflows and support rapid growth, emphasizing the positive impact on patient service [4] - Waystar serves over 30,000 clients, representing over 1 million distinct providers, and processes over 7.5 billion healthcare payment transactions annually, amounting to over $2.4 trillion in gross claims [7]